Related Experiment Video
Updated: Mar 16, 2026

Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System
Published on: May 24, 2017
Smokers' and e-cigarette users' perceptions of modified risk warnings for e-cigarettes.
Olivia A Wackowski1, Richard J O'Connor2, Andrew A Strasser3
1Department of Health Education & Behavioral Science, Center for Tobacco Studies, Rutgers School of Public Health, 335 George Street, Suite 2100, New Brunswick, NJ 08901, United States.
Modified risk warnings for e-cigarettes face skepticism. Consumers found comparative risk statements potentially misleading, highlighting the need for clearer communication strategies to avoid misinterpretation and ensure public health benefits.
Area of Science:
- Public Health
- Tobacco Control
- Risk Communication
Background:
- The Family Smoking Prevention and Tobacco Control Act allows modified risk tobacco product applications.
- Limited research exists on communicating comparative tobacco risks and their interpretation.
Purpose of the Study:
- To qualitatively examine perceptions of potential modified risk statements for e-cigarettes.
- To understand how consumers interpret comparative risk messages on e-cigarette warning labels.
Main Methods:
- Conducted six focus groups with 27 adult e-cigarette users and cigarette-only smokers.
- Evaluated two versions of modified risk warning statements for e-cigarettes.
Main Results:
- Participants believed e-cigarettes are safer than cigarettes but were skeptical of warning labels.
- "Substantially lower risks" phrasing was perceived as misleading and difficult to understand.
- An alternative warning was considered stronger and more specific by some participants.
Conclusions:
- Modified risk messages for e-cigarettes can influence perceptions and product use.
- Further research is needed on message framing, wording, and placement for optimal public health impact.
- Clearer communication is essential to maximize benefits and minimize harms associated with modified risk claims.
More Related Videos
08:39Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
Published on: August 25, 2018
09:30A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
Published on: January 18, 2018
Related Concept Videos
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Relative Risk
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
FDA Approved Drugs: Changes to Approved Drugs
Stress Prevention and Stress Management Techniques IV